Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Renal denervation: ultima ratio or standard in treatment-resistant hypertension.

Literature DB >> 22851728

Renal denervation: ultima ratio or standard in treatment-resistant hypertension.

Alexandre Persu¹, Jean Renkin, Lutgarde Thijs, Jan A Staessen.

Abstract

Entities: Chemical

Mesh：

Substances：
Antihypertensive Agents

Year: 2012 PMID： 22851728 PMCID： PMC3607230 DOI： 10.1161/HYPERTENSIONAHA.112.195263

Source DB: PubMed Journal: Hypertension ISSN： 0194-911X Impact factor: 10.190

× No keyword cloud information.

90 in total

Review 1. Resistant hypertension.

Authors: Robert H Fagard
Journal: Heart Date: 2012-02 Impact factor: 5.994

2. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension.

Authors: Mathias C Brandt; Felix Mahfoud; Sara Reda; Stephan H Schirmer; Erland Erdmann; Michael Böhm; Uta C Hoppe
Journal: J Am Coll Cardiol Date: 2012-03-06 Impact factor: 24.094

3. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure.

Authors: Michael E Ernst; Barry L Carter; Chris J Goerdt; Jennifer J G Steffensmeier; Beth Bryles Phillips; M Bridget Zimmerman; George R Bergus
Journal: Hypertension Date: 2006-01-23 Impact factor: 10.190

4. Renal sympathetic-nerve ablation for uncontrolled hypertension.

Authors: Markus P Schlaich; Paul A Sobotka; Henry Krum; Elisabeth Lambert; Murray D Esler
Journal: N Engl J Med Date: 2009-08-27 Impact factor: 91.245

5. Comparing methods of measurement: why plotting difference against standard method is misleading.

Authors: J M Bland; D G Altman
Journal: Lancet Date: 1995-10-21 Impact factor: 79.321

6. Aortoiliac and lower extremity arteries assessed with 16-detector row CT angiography: prospective comparison with digital subtraction angiography.

Authors: Jürgen K Willmann; Bernhard Baumert; Thomas Schertler; Simon Wildermuth; Thomas Pfammatter; Francis R Verdun; Burkhardt Seifert; Borut Marincek; Thomas Böhm
Journal: Radiology Date: 2005-07-29 Impact factor: 11.105

7. Concurrent and predictive validity of a self-reported measure of medication adherence.

Authors: D E Morisky; L W Green; D M Levine
Journal: Med Care Date: 1986-01 Impact factor: 2.983

8. Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial.

Authors: David E Kandzari; Deepak L Bhatt; Paul A Sobotka; William W O'Neill; Murray Esler; John M Flack; Barry T Katzen; Martin B Leon; Joseph M Massaro; Manuela Negoita; Suzanne Oparil; Krishna Rocha-Singh; Craig Straley; Raymond R Townsend; George Bakris
Journal: Clin Cardiol Date: 2012-05-09 Impact factor: 2.882

9. Adherence to long-term therapies: evidence for action.

Authors: Sabina De Geest; Eduardo Sabaté
Journal: Eur J Cardiovasc Nurs Date: 2003-12 Impact factor: 3.908

10. Pattern of heart failure in Abuja, Nigeria: an echocardiographic study.

Authors: D B Ojji; J Alfa; S O Ajayi; M H Mamven; A O Falase
Journal: Cardiovasc J Afr Date: 2009 Nov-Dec Impact factor: 1.167

29 in total

Review 1. Renal sympathetic denervation: applications in hypertension and beyond.

Authors: Michael Böhm; Dominik Linz; Daniel Urban; Felix Mahfoud; Christian Ukena
Journal: Nat Rev Cardiol Date: 2013-06-18 Impact factor: 32.419

2. Renal Denervation Prevents Immune Cell Activation and Renal Inflammation in Angiotensin II-Induced Hypertension.

Authors: Liang Xiao; Annet Kirabo; Jing Wu; Mohamed A Saleh; Linjue Zhu; Feng Wang; Takamune Takahashi; Roxana Loperena; Jason D Foss; Raymond L Mernaugh; Wei Chen; Jackson Roberts; John W Osborn; Hana A Itani; David G Harrison
Journal: Circ Res Date: 2015-07-08 Impact factor: 17.367

Renal denervation: ultima ratio or standard in treatment-resistant hypertension.

Review 1. Resistant hypertension.

2. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension.

3. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure.

4. Renal sympathetic-nerve ablation for uncontrolled hypertension.

5. Comparing methods of measurement: why plotting difference against standard method is misleading.

6. Aortoiliac and lower extremity arteries assessed with 16-detector row CT angiography: prospective comparison with digital subtraction angiography.

7. Concurrent and predictive validity of a self-reported measure of medication adherence.

8. Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial.

9. Adherence to long-term therapies: evidence for action.

10. Pattern of heart failure in Abuja, Nigeria: an echocardiographic study.

Review 1. Renal sympathetic denervation: applications in hypertension and beyond.

2. Renal Denervation Prevents Immune Cell Activation and Renal Inflammation in Angiotensin II-Induced Hypertension.

3. Blood pressure response to renal nerve stimulation in patients undergoing renal denervation: a feasibility study.

4. Where hypertension happens.

Review 5. Assessment and management of resistant hypertension.

Review 6. Renal Denervation After Symplicity HTN-3 - Back to Basics. Review of the Evidence.

Review 7. Renal Denervation for Resistant Hypertension: Past, Present, and Future.

Review 8. Renal denervation in the treatment of hypertension.

Review 9. Renal Denervation for Treatment of Hypertension: a Second Start and New Challenges.

Review 10. Treatment resistant hypertension--investigation and conservative management.